Skip to main content
OpenTrials
Completed

NCT Number: NCT07569627

Effects of BFR-training on Stem Cells and Immune Cells in Human Skeletal Muscle

In this 3-year project, investigators will first measure stem cells (primary outcome) and immune cells (secondary outcome) in human skeletal muscle immediately after and 24 hour after the BFR-training. In the second and third year, the effect of β-NMN (vitamin B3 precursor) and antioxidant on the same outcomes after BFR-exercise will be assessed. The BFR-exercise in the study will consist of a 5 × 10-second sprinting with maximal voluntary efforts, 5 minutes after a BFR pre-conditioning to legs using pressurized cuffs. In Study 1 (1st year, N = 24, aged 20-30 year), a randomized crossover trial will be conducted to compare the efficacy of sprinting exercise using BFR pre-conditioning at 20 mmHg (control) or 180 mmHg (occlusion). Study 2 (2nd year, N = 24, aged 20-30 years) will be conducted to examine the effect of β-NMN supplementation on the aforementioned outcomes in human muscles using a randomized placebo-controlled crossover study design. Study 3 (third year, N = 24, aged 20-30 years) will be conducted to examine the effect of vitamin C on the same variables immediately after and 24 hours after resistance exercise intervention, using a randomized placebo-controlled crossover study design.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Laboratory of Exercise Biochemistry

Taipei, Taiwan, 111

About this study

Primary outcome: Stem cells (Stro-1+ cells) assessed by immunofluorescence staining.

Secondary outcome: Immune cells (MPO+ cells) assessed by immunofluorescence staining.

Study 1: Two-arm intervention (counterbalanced crossover design): Sham-exercise, BFR-exercise Study 2: Two-arm intervention (counterbalanced crossover design): Placebo-BFR exercise, NMN-BFR exercise Study 3: Two-arm intervention (counterbalanced crossover design): Placebo-BFR exercise, Vitamin C-BFR exercise

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy men

Exclusion criteria

  • inflammatory or immune conditions

Treatment and study plan

BFR (180 mmHg)

Behavioral

Sprinting exercise after BFR

Other names: Sham (20 mmHg)

NMN-BFR exercise

Dietary Supplement

NMN ingested before and after BFR exercise

Other names: Placebo-BFR exercise

Vitamin C-resistance exercise

Dietary Supplement

Vitamin C ingested before and after resistance exercise

Other names: Placebo-resistance exercise

Primary outcomes

  1. Stem cells in muscle

    Time frame: Pre-exercise, immediately post-exercise, and 24-hour post-challenge (BFR-exercise) recovery

    Stem cells are identified by Stro-1 cell marker

Secondary outcomes

  1. Immune cells in muscle

    Time frame: At 24-hour post-challenge recovery

    Immune cells are identified by myeloperoxidase (MPO) cell marker

Sponsors and collaborators

Lead sponsor

University of Taipei

Other

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
May 6, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.